Sotera Health Co

SHC Nasdaq SEC CIK 1822479
Follow Sotera Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $324.9M +4.4% vs same quarter last year
Net income $58.4M +20.6% vs same quarter last year
EPS, diluted $0.20 +17.6% vs same quarter last year
Operating cash flow $110.5M +55.4% vs same quarter last year
Revenue by quarter
$290.2M
$254.5M
$294.3M
$311.3M
$303.4M
$280M
$321.4M
$324.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.2B$77.9M
FY24$1.1B$44.4M
FY23$1B$51.4M
FY22$1B−$233.6M
FY21$931.5M$116.2M
FY20$818.2M−$38.6M
FY19$778.3M−$20.9M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40%−20%0%20%40%60%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2555.5%-6.7%
FY2454.7%27%4%
FY2355%26.4%4.9%
FY2255.5%24.7%−23.3%
FY2155.7%27.6%12.5%
FY2054.2%25.2%−4.7%
FY1950.8%23.6%−2.7%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$149.2M
FY24$45.1M
FY23−$362.7M
FY22$95.6M
FY21$179.4M
FY20$67.1M
FY19$91.8M
FY18-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200M$400M$600M$800MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25--
FY24--
FY23--
FY22-$0
FY21$0$0
FY20$0$34M
FY19$691.2M$0
FY18--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sotera Health
  • Healthcare median
−100%−75%−50%−25%0%25%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSotera HealthHealthcare median
FY256.7%−30.6%
FY244%−47%
FY234.9%−58%
FY22−23.3%−80.4%
FY2112.5%−71.9%
FY20−4.7%−62.2%
FY19−2.7%−46.3%
FY18-−49.6%